Literature DB >> 16332590

Dose-effect models for risk-relationship to cell survival parameters.

Alexandru Daşu1, Iuliana Toma-Daşu.   

Abstract

There is an increased interest in estimating the induction of cancers following radiotherapy as the patients have nowadays a much longer life expectancy following the treatment. Clinical investigations have shown that the dose response relationship for cancer induction following radiotherapy has either of two main characteristics: an increase of the risk with dose to a maximum effect followed by a decrease or an increase followed by a levelling-off of the risk. While these behaviours have been described qualitatively, there is no mathematical model that can explain both of them on mechanistic terms. This paper investigates the relationship between the shape of the dose-effect curve and the cell survival parameters of a single risk model. Dose response relationships were described with a competition model which takes into account the probability to induce DNA mutations and the probability of cell survival after irradiation. The shape of the curves was analysed in relation to the parameters that have been used to obtain them. It was found that the two main appearances of clinical data for the induction of secondary cancer following radiotherapy could be the manifestations of the particular sets of parameters that describe the induction of mutations and cell kill for fractionated irradiations. Thus, the levelling off appearance of the dose response curve could be either a sign of moderate to high inducible repair effect in cell survival (but weak for DNA mutations) or the effect of heterogeneity, or both. The bell-shaped appearance encompasses all the other cases. The results also stress the importance of taking into account the details of the clinical delivery of dose in radiotherapy, mainly the fractionated character, as the findings of our study did not appear for single dose models. The results thus indicate that the shapes of clinically observed dose response curves for the induction of secondary cancers can be described by using one single competition model. It was also found that data for cancer induction may be linked to in vivo cell survival parameters that may be used for other modelling applications.

Entities:  

Mesh:

Year:  2005        PMID: 16332590     DOI: 10.1080/02841860500401159

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  9 in total

1.  Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.

Authors:  Laura A Rechner; Rebecca M Howell; Rui Zhang; Carol Etzel; Andrew K Lee; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2012-10-10       Impact factor: 3.609

2.  Breast cancer and funnel chest. Comparing helical tomotherapy and three-dimensional conformal radiotherapy with regard to the shape of pectus excavatum.

Authors:  M Uhl; F Sterzing; G Habl; K Schubert; H Holger; J Debus; K Herfarth
Journal:  Strahlenther Onkol       Date:  2012-01-06       Impact factor: 3.621

3.  Dose and dose rate extrapolation factors for malignant and non-malignant health endpoints after exposure to gamma and neutron radiation.

Authors:  Van Tran; Mark P Little
Journal:  Radiat Environ Biophys       Date:  2017-09-22       Impact factor: 1.925

4.  Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.

Authors:  Uwe Schneider; Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2007-12-21       Impact factor: 1.925

5.  Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.

Authors:  Uwe Schneider; Marcin Sumila; Judith Robotka
Journal:  Theor Biol Med Model       Date:  2011-07-26       Impact factor: 2.432

Review 6.  Second primary cancers after radiation for prostate cancer: a review of data from planning studies.

Authors:  Louise Murray; Ann Henry; Peter Hoskin; Frank-Andre Siebert; Jack Venselaar
Journal:  Radiat Oncol       Date:  2013-07-08       Impact factor: 3.481

7.  Modeling the risk of secondary malignancies after radiotherapy.

Authors:  Uwe Schneider
Journal:  Genes (Basel)       Date:  2011-11-29       Impact factor: 4.096

8.  A software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses.

Authors:  Eleftherios Tzanis; Michael Mazonakis; John Damilakis
Journal:  Rep Pract Oncol Radiother       Date:  2022-03-22

9.  Secondary malignancy risk for patients with localized prostate cancer after intensity-modulated radiotherapy with and without flattening filter.

Authors:  Marius Treutwein; Rainer Loeschel; Matthias Hipp; Oliver Koelbl; Barbara Dobler
Journal:  J Appl Clin Med Phys       Date:  2020-11-04       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.